Kalos; Michael D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kalos; Michael D..The latest application filed is for "compositions and methods for regulating car t cells".

Company Profile

2.38.77

Kalos; Michael D. - Philadelphia PA
Kalos; Michael D. - New York NY
Kalos; Michael D. - Philadelphila PA
Kalos; Michael D. - Pasadena CA
Kalos; Michael D. - Seattle WA
Kalos; Michael D. - Duarte CA
Kalos; Michael D - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Toxicity management for anti-tumor activity of CARs Grant 11,273,219 - June , et al. March 15, 2	2022-03-15
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells Grant 11,028,177 - Brogdon , et al. June 8, 2	2021-06-08
Toxicity management for anti-tumor activity of CARs Grant 10,603,378 - June , et al.	2020-03-31
Compositions and Methods for Regulating CAR T Cells App 20190367610 - June; Carl H. ; et al.	2019-12-05
Use Of Cart19 To Deplete Normal B Cells To Induce Tolerance App 20180271907 - June; Carl H. ; et al.	2018-09-27
Compositions and Methods for Treatment of Cancer App 20180258391 - June; Carl H. ; et al.	2018-09-13
Toxicity Management for Anti-Tumor Activity of CARs App 20180256712 - June; Carl H. ; et al.	2018-09-13
Toxicity Management for Anti-Tumor Activity of CARs App 20180243411 - June; Carl H. ; et al.	2018-08-30
Compositions and Methods for Treatment of Cancer App 20170283775 - June; Carl H. ; et al.	2017-10-05
Effective Targeting Of Primary Human Leukemia Using Anti-cd123 Chimeric Antigen Receptor Engineered T Cells App 20170183415 - Brogdon; Jennifer ; et al.	2017-06-29
Methods for assessing the suitability of transduced T cells for administration Grant 9,572,836 - June , et al. February 21, 2	2017-02-21
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells Grant 9,573,988 - Brogdon , et al. February 21, 2	2017-02-21
Compositions and methods for treatment of cancer Grant 9,540,445 - June , et al. January 10, 2	2017-01-10
Compositions and methods for treatment of cancer Grant 9,518,123 - June , et al. December 13, 2	2016-12-13
Use of chimeric antigen receptor-modified T-cells to treat cancer Grant 9,499,629 - June , et al. November 22, 2	2016-11-22
Compositions and methods for treatment of cancer Grant 9,481,728 - June , et al. November 1, 2	2016-11-01
Compositions and methods for treatment of cancer Grant 9,464,140 - June , et al. October 11, 2	2016-10-11
Epitope Spreading Associated with CAR T-Cells App 20160235787 - June; Carl H. ; et al.	2016-08-18
Compositions and Methods for Treatment of Cancer App 20160208012 - June; Carl H. ; et al.	2016-07-21
Compositions and Methods for Treatment of Cancer App 20160194404 - June; Carl H. ; et al.	2016-07-07
Compositions and Methods for Treatment of Cancer App 20160159907 - June; Carl H. ; et al.	2016-06-09
Compositions and Methods for Treatment of Cancer App 20160130355 - June; Carl H. ; et al.	2016-05-12
Use of chimeric antigen receptor-modified T cells to treat cancer Grant 9,328,156 - June , et al. May 3, 2	2016-05-03
Use Of Cart19 To Deplete Normal B Cells To Induce Tolerance App 20150290244 - June; Carl H. ; et al.	2015-10-15
Methods for treatment of cancer Grant 9,101,584 - June , et al. August 11, 2	2015-08-11
Compositions for treatment of cancer Grant 9,102,761 - June , et al. August 11, 2	2015-08-11
Compositions for treatment of cancer Grant 9,102,760 - June , et al. August 11, 2	2015-08-11
Toxicity Management for Anti-Tumor Activity of CARs App 20150202286 - June; Carl H. ; et al.	2015-07-23
Methods for Assessing the Suitability of Transduced T Cells for Administration App 20150190428 - June; Carl H. ; et al.	2015-07-09
Compositions and Methods for Regulating CAR T Cells App 20150140019 - June; Carl H. ; et al.	2015-05-21
Methods for Treatment of Cancer App 20150118202 - June; Carl H. ; et al.	2015-04-30
Compositions for Treatment of Cancer App 20150099299 - June; Carl H. ; et al.	2015-04-09
Compositions for Treatment of Cancer App 20150093822 - June; Carl H. ; et al.	2015-04-02
Compositions for treatment of cancer Grant 8,975,071 - June , et al. March 10, 2	2015-03-10
Compositions for Treatment of Cancer App 20150050729 - June; Carl H. ; et al.	2015-02-19
Methods for treatment of cancer Grant 8,916,381 - June , et al. December 23, 2	2014-12-23
Methods for Treatment of Cancer App 20140370017 - June; Carl H. ; et al.	2014-12-18
Compositions for treatment of cancer Grant 8,911,993 - June , et al. December 16, 2	2014-12-16
Methods for treatment of cancer Grant 8,906,682 - June , et al. December 9, 2	2014-12-09
Effective Targeting Of Primary Human Leukemia Using Anti-cd123 Chimeric Antigen Receptor Engineered T Cells App 20140322212 - Brogdon; Jennifer ; et al.	2014-10-30
Use of Chimeric Antigen Receptor-Modified T Cells to Treat Cancer App 20140106449 - June; Carl H. ; et al.	2014-04-17
Methods for Treatment of Cancer App 20130309258 - June; Carl H. ; et al.	2013-11-21
Use of Chimeric Antigen Receptor-Modified T-Cells to Treat Cancer App 20130287748 - June; Carl H. ; et al.	2013-10-31
Compositions for Treatment of Cancer App 20130288368 - June; Carl H. ; et al.	2013-10-31
Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer App 20120016340 - Xu; Jiangchun ; et al.	2012-01-19
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20110150883 - Fanger; Gary R. ; et al.	2011-06-23
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 7,939,646 - Xu , et al. May 10, 2	2011-05-10
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 7,517,952 - Xu , et al. April 14, 2	2009-04-14
Compositions And Methods For The Therapy And Diagnosis Of Lung Cancer App 20090062194 - Wang; Tongtong ; et al.	2009-03-05
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080311124 - Fanger; Gary R. ; et al.	2008-12-18
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080311123 - Fanger; Gary R. ; et al.	2008-12-18
Compositions And Methods For The Therapy And Diagnosis Of Lung Cancer App 20080292633 - Henderson; Robert A. ; et al.	2008-11-27
Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer App 20080233139 - Xu; Jiangchun ; et al.	2008-09-25
Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer App 20080226620 - Xu; Jiangchun ; et al.	2008-09-18
Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer App 20080226606 - Xu; Jiangchun ; et al.	2008-09-18
Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer App 20080226607 - Xu; Jiangchun ; et al.	2008-09-18
Compositions comprising a lung tumor antigen Grant 7,425,607 - Henderson , et al. September 16, 2	2008-09-16
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080219982 - Fanger; Gary R. ; et al.	2008-09-11
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080219990 - Fanger; Gary R. ; et al.	2008-09-11
Compositions And Methods For The Therapy And Diagnosis Of Prostate Cancer App 20080219988 - Xu; Jiangchun ; et al.	2008-09-11
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080219991 - Fanger; Gary R. ; et al.	2008-09-11
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080219989 - Fanger; Gary R. ; et al.	2008-09-11
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080206244 - Fanger; Gary R. ; et al.	2008-08-28
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080206234 - Fanger; Gary R. ; et al.	2008-08-28
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080206245 - Fanger; Gary R. ; et al.	2008-08-28
Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer App 20080206249 - Fanger; Gary R. ; et al.	2008-08-28
Compositions And Methods For The Therapy And Diagnosis Of Lung Cancer App 20080171690 - Henderson; Robert A. ; et al.	2008-07-17
Compositions And Methods For The Therapy And Diagnosis Of Lung Cancer App 20080171048 - Henderson; Robert A. ; et al.	2008-07-17
Compositions and methods for the therapy and diagnosis of lung cancer App 20070154488 - Wang; Tongtong ; et al.	2007-07-05
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 7,202,342 - Xu , et al. April 10, 2	2007-04-10
Compositions and methods for the therapy and diagnosis of breast cancer App 20060287513 - Fanger; Gary R. ; et al.	2006-12-21
Compositions and methods for the therapy and diagnosis of prostate cancer App 20060269532 - Xu; Jiangchun ; et al.	2006-11-30
Compositions and methods for therapy and diagnosis of prostate cancer Grant 7,074,898 - Xu , et al. July 11, 2	2006-07-11
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 7,048,931 - Xu , et al. May 23, 2	2006-05-23
Methods for diagnosis of lung cancer Grant 7,049,063 - Wang , et al. May 23, 2	2006-05-23
Compositions and methods for the therapy and diagnosis of lung cancer App 20060088527 - Henderson; Robert A. ; et al.	2006-04-27
Prostate-specific polynucleotide compositions Grant 7,033,827 - Xu , et al. April 25, 2	2006-04-25
Prostate-specific polypeptides and fusion polypeptides thereof App 20060024301 - Xu; Jiangchun ; et al.	2006-02-02
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 6,943,236 - Xu , et al. September 13, 2	2005-09-13
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 6,894,146 - Xu , et al. May 17, 2	2005-05-17
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 6,818,751 - Xu , et al. November 16, 2	2004-11-16
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 6,800,746 - Xu , et al. October 5, 2	2004-10-05
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 6,759,515 - Xu , et al. July 6, 2	2004-07-06
Compositions and methods for the therapy and diagnosis of lung cancer Grant 6,737,514 - Wang , et al. May 18, 2	2004-05-18
Compounds and methods for therapy and diagnosis of lung cancer Grant 6,706,262 - Wang , et al. March 16, 2	2004-03-16
Compositions and methods for the therapy and diagnosis of lung cancer App 20030211510 - Henderson, Robert A. ; et al.	2003-11-13
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 6,630,305 - Xu , et al. October 7, 2	2003-10-07
Compositions and methods for the therapy and diagnosis of prostate cancer App 20030185830 - Xu, Jiangchun ; et al.	2003-10-02
Compositions and methods for the therapy and diagnosis of prostate cancer Grant 6,620,922 - Xu , et al. September 16, 2	2003-09-16
Compositions and methods for the therapy and diagnosis of lung cancer App 20030170255 - Watanabe, Yoshihiro ; et al.	2003-09-11
Compositions and methods for the therapy and diagnosis of prostate cancer App 20030157089 - Xu, Jiangchun ; et al.	2003-08-21
Compositions and methods for the therapy and diagnosis of lung cancer App 20030138438 - Mericle, Barbara ; et al.	2003-07-24
Compositions and methods for the therapy and diagnosis of breast cancer App 20030125536 - Fanger, Gary R. ; et al.	2003-07-03
Compositions and methods for the therapy and diagnosis of lung cancer App 20030103994 - Watanabe, Yoshihiro ; et al.	2003-06-05
Compositions and methods for therapy and diagnosis of prostate cancer App 20030088062 - Xu, Jiangchun ; et al.	2003-05-08
Compositions and methods for the therapy and diagnosis of pancreatic cancer App 20030073144 - Benson, Darin R. ; et al.	2003-04-17
Compositions and methods for the therapy and diagnosis of lung cancer App 20030064947 - Wang, Tongtong ; et al.	2003-04-03
Compositions and methods for the therapy and diagnosis of Her-2/neu-associated malignancies App 20020193329 - Hand-Zimmermann, Susan ; et al.	2002-12-19
Compositions and methods for the therapy and diagnosis of prostate cancer App 20020193296 - Xu, Jiangchun ; et al.	2002-12-19
Compositions and methods for the therapy and diagnosis of prostate cancer App 20020192763 - Xu, Jiangchun ; et al.	2002-12-19
Compositions and methods for the therapy and diagnosis of prostate cancer App 20020183251 - Xu, Jiangchun ; et al.	2002-12-05
Compositions and methods for the therapy and diagnosis of lung cancer App 20020115139 - Kalos, Michael D. ; et al.	2002-08-22
Compositions and methods for the therapy and diagnosis of lung cancer App 20020110563 - Reed, Steven G. ; et al.	2002-08-15
Compositions and methods for the therapy and diagnosis of lung cancer App 20020099012 - Wang, Tongtong ; et al.	2002-07-25
Compositions and methods for the therapy and diagnosis of prostate cancer App 20020081680 - Xu, Jiangchun ; et al.	2002-06-27
Compositions and methods for the therapy and diagnosis of pancreatic cancer App 20020082207 - Hirst, Shannon K. ; et al.	2002-06-27
Compositions and methods for the therapy and diagnosis of pancreatic cancer App 20020076721 - Pyle, Ruth A. ; et al.	2002-06-20
Compositions and methods for the therapy and diagnosis of prostate cancer App 20020051977 - Xu, Jiangchun ; et al.	2002-05-02
Compositions and methods for the therapy and diagnosis of lung cancer App 20020052329 - Wang, Tongtong ; et al.	2002-05-02
Compositions and methods for the therapy and diagnosis of prostate cancer App 20020022248 - Xu, Jiangchun ; et al.	2002-02-21
Compositions and methods for therapy and diagnosis of prostate cancer Grant 6,329,505 - Xu , et al. December 11, 2	2001-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.